Drug Approval | September 28, 2024
FDA approves Bristol Myers Squibb’s Cobenfy
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Coupled with Shea Butter, Cocoa Butter, and Mango Butter, the balm provides deep hydration, ensuring lips remain soft, smooth, and well-moisturized throughout the day
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
Birajeev is a seasoned Supply Chain leader with an experience of 23 years
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
Subscribe To Our Newsletter & Stay Updated
